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Chronic activation of the sympathetic nervous system may be a pathogenetic mechanism by which liyperinsulinemia induces cardiovascular damage in insulin-resis tant NIDDM patients. The influence of physiological hyperinsulinemia ( 700 pmol/l) on basal and stimulated sympathetic outflow was studied in 12 lean normotensive subjects with well-controlled NIDDM without complica tions and in 13 matched control subjects. Forearm blood llow (FBF) was measured with forearm plethysmography; sympathetic nervous system activity was assessed by the ['TI]norepinephrine (NE) tracer method* NIDDM patients were insulin resistant (glucose infusion rates 31.8 ± 3.8 vs. 48.7 ± 2.0 fjunol • kg ' 1 4 min 1 in control subjects, P < 0.01). After a mixed meal, NIDDM patients showed a hyperinsulinemic response (2-h insulin levels; NIDDM patients 321 ± 31 pmol/l, control subjects 165 ± If) pmol/l, P < 0.001). Insulin infusion induced a vasodilator response (not significantly different between the groups). Arterial plasma NE levels and total-body NE spillover increased significantly (total spillover in NIDDM patients from 0.77 ± 0.09 to 1.18 ± 0.16 nmol * m ~ • min in control subjects from 0,98 ± 0.14 to 1.23 ± 0.18 nmol m 2 min "1, P < 0.01 for all, not; different between groups). Total-body NE clearance did not change. Sympathetic stimulation (lower-body nega tive pressure [LBNP] 15 mmllg) induced forearm vaso constriction and increased arterial and venous plasma NE and total NE spillover. Responses of FBF and NE kinetics to LBNP were not significantly different between groups and were not altered by hyperinsulinemia. Although these nonobcsc subjects with uncomplicated NIDDM showed postprandial hyperinsulinemia and resistance to the ef fect of insulin on glucose metabolism, this group was not resistant to the vasodilator and sympathetic stimulant effects of insulin. Responses to sympathetic stimuli (LBNP) were normal and unaffected by physiological hyperinsulinemia. Therefore, because of daily life hyper insulinemia, chronic sympathetic stimulation could be operative in these patients and may explain the increased incidence of hypertension and/or cardiovascular compli cations. Diabetes 45: [15] [16] [17] [18] [19] [20] [21] [22] 1990 Kmm til. A s a consequence of insulin resistance, hyperinsulinemia has been related to disorders such as hypertension, obesity, dyslipidemia, and NIDDM (1-3). Furtherm ore, hyperinsulinemia has been directly associated with atherosclerosis and cardiovascular events (4-0). The cause of this relationship bet ween hyper insulinemia and cardiovascular morbidity is not clear, but it may be mediated by som e cardiovascular effect of insulin. Besides insulin's key role in the regulat ion of carbohydrate metabolism (7) , it has becom e clear that it also has important effects on the cardiovascular system (8, 9) . In acute experi ments in humans, insulin infusion exerts a vasodilatory elled ( 1 0 ,1 1 ). In addition, acute hyperinsulinem ia induces systciuh sympathetic activation as m easured by direct muscle sy1 pathetic nerve activity (MSNA) recordings (11, 12) . Togo!' insulin-induced vasodilation and sympathetic stimulat will induce a state of hyperdynam ic circulation, character ized by a high heart, rate, wide pulse pressure, and increased cardiac output. Recent epidemiological studies, indeed, Rmncl a relationship betw een a hyperdynamic circulation and insulin resistance (13, 14) .
( 'outinuous sym pathetic stim ulation has been related to increased cardiovascular morbidity ( lfi), Chronic stimulation of the sympathetic nervous system due to chronic hyperinsulinemia could therefore be an important factor explaining the well-known increased incidence of cardiovascular dis ease that can be observed in NIDDM patients (lb). Therefore, it seems a valid question w hether individuals with chronic hyperinsulinemia, which holds true for the initial phase of NIDDM, are exposed to normal insulin-induced sympathetic stimulation. In patients with long-standing established NIDDM, resistance to the vasodilatory effects of insulin has been reported (17, 18) . Data on the early phase of NIDDM are lacking, while endogenous hyperinsulinem ia is most promi nent at this early stage (19, 20) . Moreover, the ability of insulin to stimulate sym pathetic neural outflow in NIDDM has not been exam ined before1.
In the present study, we hypothesized that NIDDM pa tients in the early phase of their disease are still sensitive to the sympathetic stimulant effects of insulin. To address our hypothesis, sym pathetic nervous activity was investigated at baseline and during stim ulation, both before and during acute hyperinsulinemia, in patients with early mild uncom plicated NIDDM and well-matched healthy control subjects. To quantify the response of the sympathetic nervous system in detail, the [3H ] norepinephrine (NE) tracer technique was used (21). r e s e a r c h d e s i g n a n d m e t h o d s Subjects. The study group consisted of 13 patients with NIDDM. All met. the inclusion criteria* age between 25 and 00 years, nonsmoking, absence of hypertension (office blood pressure <160/90 mmHg, mea sured after a 5-min rest in the supine position), absence of maciovascular and microvascular complications, as assessed by physical examination (normal tendon reflexes and normal vibration sense), normal ophthalmoscopic examination, normal renal function and albu min excretion rate (<20 |xg/min), body mass index <27 kg/nr, and good metabolic control (HbAlc <7.5%) with diet alone or low doses of the first-generation sulfonylurea derivative tolbutamide (^1,000 mg/day). Participants used no other medication. Patients were recruited from our outpatient department (of -700 NIDDM patients* 11 met, the inclusion criteria, of whom 6 participated) and through calls for patients treated by general practitioners ('-SO candidates, of whom 7 w eie included). Of the 13 patients, 10 had a family history positive for diabetes. One of these, who had NIDDM diagnosed before the age of 25 years, could be classified as having maturity-onset diabetes of the young and was excluded from further analysis because the etiology of this disease is different (22). Mean diabetes duration was 4 5 ± 6 .0 years (mean ± SD).
A control group consisted of 13 healthy, lean, normotensive, and nonsmoking (meeting the above-mentioned criteria) age-and sexmatched subjects. These participants were selected by advertisement and received a payment. All of these subjects had normal glucose tolerance and a family history negative for diabetes and hypertension. All participants gave written informed consent. The experimental pro tocol was approved by the hospital ethics committee. Experim ental procedures and p ro to co l. Before the experiment, all participants underwent a mixed-meal test. After an overnight fast, they ingested a liquid meal containing 25 g proteins, 18 g lipids, and 72 g carbohydrates, partly disaccharides, including gelatin and fibers (total energy content 548 calories). Before and after 30j 60, 120, and 180 nun, blood samples were taken for plasma insulin and glucose determina tions.
Within 7 days after the mixed-meal test, the main experiment w as performed after an overnight fast with the subjects in supine position in a quiet temperature-controlled room (25-26° C). Under local anesthesia (0.3-0.4 ml lidocaine HC1, 20 mg/ml), a 20-gauge catheter (Angiocath, Becton Dickinson, Sandy, Utah) was inserted into the left brachial artery and connected with an arterial pressure monitoring line (Viggo Spectrained, 5269-129) to a Hewlett Packard 78353B monitor. In the sam e arm, a catheter (Venfion, 20 gauge, 32 mm) was inserted into a deep forearm vein to obtain venous blood samples. On the contralateral side, an identical catheter was inserted into a large forearm vein for the infusion of [3H]NE, insulin, and 20% glucose. After complete instrumen tation, at least 30 min of rest were included.
Previously prepared aliquots of [°H]NE were thawed and diluted with 0.9% saline to an activity of 4 i^Ci/ml. The weight o f the syringe containing the radiotracer was measured just before and just alter the infusion to verify the infusion rate. At the end of the experiment, a portion of the radiotracer w as frozen and stored at -8 0°C for analysis at the time the plasma determination was performed. After a priming dose of 15 jxCi/m2, a continuous infusion of 0.35 |xCi ■ m " 2 • m in' 1 [;,H]NE was given during the entire experiment. Again, 30 min were allowed to obtain a steady state, after which baseline hemodynamic and humoral m ea surements were performed. Then, lower-body negative pressure (LBNP) at -1 5 mmHg, using a Perspex box, was applied for 15 min to stimulate the sympathetic nervous system (23). Subsequently, 30 min were again taken to allow all parameters to return toward baseline level The hyperinsulinemic euglycemic clamp was then started and w as continued for 90 min. During insulin infusion, hemodynamic data w ere obtained at 20-min intervals and NE Idnetic measurements were obtained at 45 and 90 min. Plasma insulin concentrations were measured after 60 and 90 min. Finally, with the continuation o f insulin and glucose infusion, a second application of LBNP at -1 5 mmHg w as performed for 15 min. A schedule of the study protocol is shown in Fig. 1. Forearm blood flow (FBF) w as measured using mercury-in-Silastic ® ?^S a u g e venous occlusion plethysmography as previously described (24). One minute before the start of the measurements, a wrist cuff w as 
Normal 
at the beginning of (ho NF peak position in the chromatogram of the standard solution, which was run before the plasma samples and Forearm vascular resistance (FVR) was calculated by dividing mean arterial pressure by FBF and was expressed in arbitrary units (AD).
Pulse pressure was calculated by subtracting diastolic from systolic blood pressure.
Since some parameters of NE kinetics showed a non-Gaussian distribution, statistical analysis of these data was performed using a nonparamolric paired analysis (Wiicoxon). The Mann-Whitney U test was used to compare the NE kinetic responses of diabetic patients with those of healthy individuals. Effects of insulin on hemodynamic param eters were calculated using repeated-mensures analysis of variance (ANOVA) w'ilh insulin as the dependent factor. All other (mainly metabolic) data met requirements of normality and were statistically analyzed with the Student's t test. Correlations wore calculated using Spearman's rank correlation test«. All statistical analyses were per formed using the SPSS personal computer software package, Results in tables ami figures are expressed as means ± SE unless otherwise indicated. Statistical significance was set at P < 0.05. Fig. 3 .
RESULTS

Baseline
There were no significant differences in hemodynamic* parameters between NIDDM patients and control subjects at different time points; nor were there significant differences in hemodynamic responses to insulin. Effect of insulin on NE kinetics. Absolute NE kinetic data for the entire experiment are given in Table 2 (Table 2) .
. During insulin infusion, arterial and venous NE concentrations increased (percentage increases after 45 and 90 min: arterial NE in
[control], P < 0,01 for both), Total-body NE clearance did not change during hyperinsulinemia (percentage changes after DO min: 3.7 The' quantitative responses to insulin were not significantly different. between NIDDM patients and control subjects ( Figs. 4 and 5) . Effect o f LBNP. LBNP induced vasoconstriction (FVE: 30.f) ± 4.5 to 4S.7 8 . 5 A tÎ [NIDDM) vs. 34,7 ± 4.0 to 40.0 ± 0.5 AT I [control], P < 0,05 for both) without affecting blood pressure» and heart rate (Fig. 3) . Responses of NE kinetics to LBNP are denoted in Table 2 . Arterial and venous NE as well as total-body NE spillover increased significantly, and fore arm NE spillover remained unchanged ( Figs. 4 and 5) . Responses in NIDDM patient« wore not different from those in control subjects. After this first LBNP, all parameters returned to baseline values, as can also be seen in Table 2 . Effect o f h y p erh isu lin em ia on LBNP responses, Three NIDDM patients developed presyncopal symptoms of dizzi ness anti nausea during the second LBNP, which was then interrupted. Hypoglycemia was excluded. Blood samples of these subjects taken just before the interruption were not used in the* analysis. If they were used, however, the conclu sions would be the same.
In addition, during hyperinsulinemia, LBNP induced vaso constriction (FVR in NIDDM patients [v = 0] 24. 1 (Table 2) . and heart rate (Fig. 3) . Arterial and venous NE increased ( Table 2 and Figs. 4 and 5) , and total-body NE spillover tended to increase, but; not; significantly. Baseline levels at the start of this LBNP were higher (previous insulin effect;), but; absolute responses to LBNP on both occasions were not different. Here again, the t wo study groups responded simi larly. LBNP. In contrast, this group was resistant to the effect of is not necessarily the same as the rate of NE release from insulin on glucose metabolism and was hyperinsulinemic after a regular meal. These observations imply that NIDDM patients at this early stage of their disease might be exposed to insulin-induced vasodilation and sympathetic stimulation because of their hyperinsulinemia throughout the day. We speculate that the combination of increased skeletal muscle blood flow and increments in heart rate and pulse pressure, reflecting a hyperdynamic state, could be important in the development of hypertension and/or cardiovascular compli cations later in the course of the disease.
Control experim ents. In four young healthy volunteers
Metabolic effects o f insulin. Most NIDDM patients pass through prediabetic and early diabetic stages (20), charac terized by high fasting and postprandial insulin levels (19,29) with concomitant existence of insulin resistance (30). In this study, we tried to select a group with very early NIDDM, maldng it as homogeneous as possible by using strict selec tion criteria. This patient group is exceptional from a clinical point of view; in most patients, the diabetic state is more advanced and patients are obese and have complications or comorbidity. Our nonobese NIDDM subjects were indeed insulin resistant, as has been reported before (31). Insulin sensitivity was assessed before the second LBNP and a sufficient time after the first LBNP to allow all parameters to return to baseline; hence, the determination of insulin sen sitivity could not be influenced by these sympathetic stimu latory procedures. In NIDDM, proinsulin and proinsulin-split products have been found to be elevated (32,33) and may explain part of the measured hyperinsulinemia (27,34). However, using a spe cific insulin assay, we were still able to demonstrate that our NIDDM group showed true hyperinsulinemia, as were others (19). Vasodilator response to insulin. Since 1990, a number of groups have demonstrated the vasodilatory effect of sys temic hyperinsulinemia (10,11,35). In NIDDM patients, Laakso et al. (17) have reported a decrease in insulin-induced vasodilation, partly reversible by improving metabolic con trol with insulin therapy (18). The reported studies, however, concern individuals with long-standing established diabetes who are in poor metabolic control and are considerably obese. This may be an important drawback because, as mentioned above, in NIDDM, endogenous hyperinsulinemia can be found especially in the early phase of the disease. Furthermore, insulin-induced vasodilation is attenuated in obesity itself (10,36). Recently it has also been reported that insulin-induced vasodilation was preserved in NIDDM sub jects (37), a finding that is compatible with our results. (8, 9, 11) , with the earliest report being from Gundersen and Christensen (38). The venous NE concentration, however, results from total NE production and clearance on the one hand, local production and removal on the other hand, and blood flow. By measuring not only venous but also arterial blood samples and by using tracer NE infusion (21), afar more detailed estimate of sympathetic neural activity is possible. It is, however, important to realize that the [ H]NE kinetic tracer technique represents only the rate by which NE is entering the plasma compartment, which 20 sympathetic nerve endings.
Sympathetic stimulant effects o f insulin. The relation ship between insulin and the sympathetic nervous system has been studied using variable techniques. Some studies have reported an increase in venous plasma NE concentra tions during insulin infusion
With the use of microneurographic, readings (MSNA), the insulin-induced increase in sympathetic nervous system ac tivity has been quite consistently report ed (11,12,8^39) . The MSNA technique has drawbacks ¿is well as advant ages. II-is technically demanding and is unsuccessful in a proportion of cases. Moreover, neural outflow at only one location is measured, which does not necessarily reflect; total sympa thetic activity. Until now, data on sympathetic responses in NIDDM patients have been sparse. As we show in our study, 90 min of physiological hyperinsulinemia induced an in crease of total-body NE spillover. Since this spillover is an index of sympathoneural activity, our data indicate that; hyperinsulinemia induces sympathoneural stimulation. This sympathetic stimulation was of a moderate degree, around the same magnitude as stimulation induced by LBNP of -1 5 mmHg. The insulin-induced sympathetic stimulation was clearly similar in both experimental groups.
Insulin concentrations during the clamp were, neverthe less, slightly higher in the NIDDM group, which is proba bly caused by a diminished insulin clearance, a feature coupled with insulin resistance (26,41,42). The difference in insulin level between the groups was small, however; furthermore, not only concentration but also duration of hyperinsulinemia seems to be important with respect to sympathetic stimulation (11). Finally, the relationship be tween insulin concentration and sympathetic stimulation is not linear; Vollenweider et al, (36) found comparable increases in sympathetic nerve activity (MSNA) despite threefold dif ferences in insulin concentrations. Probably sympathetic stimulation is already maximal at low insulin doses. There fore, it is highly unlikely that sympathetic responses in diabetic subjects would have been less if insulin concentra tions would have been more similar. Response to sympathetic stimuli, The diabetic subjects in our study had normal responses to the non-insulin-sympathetic stimulus LBNP, despite higher prevailing glucose levels (fasting state, diabetes versus control). Also, insulinresistant obese subjects have been reported to be normally responsive to sympathetic stimuli (Valsalva maneuver, cold pressor test, and baroreceptor activation and deactivation) (36,40), as have IDDM subjects (cold pressor test) (39). Recent work showed an increased response to hypoglycemia (to be considered as an intense sympathetic stimulation) in NIDDM (43). Thus, there is considerable evidence that, nonobese NIDDM patients have at least normal responses to sympathetic stimuli.
The response to the sympathetic stimulus LBNP was not. affected by acute hyperinsulinemia; baseline values just before the second test were indeed higher, but absolute changes were similar. These findings are in complete agree ment with the aforementioned studies of Vollenweider et al. , (39) , Mechanisms o f sympathetic activation. While we confirm the vasodilatory and sympathetic stimulant effects of insulin, we are not able to explain the mechanism of these effects. If has been demonstrated previously that activation of the sympathetic nervous system is due to hyperinsulinemia and not to glucose infusion (44,45). Hypoglycemic episodes were avoided, so sympathetic activation cannot be due to glycopenia. The observed sympathetic activation could be based on a baroreceptor reflex to a slight insulin-induced decline of DIABKTKS, VOL -15. .1AM'ARV Ill'll» blood pressure. This concept, in which vasodilation and sympathetic stimulation are coupled, is supported by the fact that in autonomous failure, insulin induces hypotension (46,47). From our data, it seems, however, that most of the sympathetic stimulation had already been established after 45 min of insulin infusion, suggesting that the activation of the sympathetic nervous system is merely a predecessor rather than a consequence of the insulin-induced vasodila tion. Pathophysiological implications. Since endogenous hy po llnsul in emia is indeed present in the fasting as well as in the postprandial state in our patients, we hypothesize that daily life hyperinsulinemia could induce a chronic stimula tion of the sympathetic nervous system. An increased sym pathetic drive lias been related to an increase in cardiovascular disease (15) and might in particular be rele vant to the development of hypertension.
Endogenous insulin levels are indeed linked to cardiovas cular risk in NIDDM subjects (48). One might speculate that as the disease proceeds, the chronic endogenous hyperinsu linemia could lead to an adaptive mechanism in which vascular and neurogenic responses are blunted. In support of this hypothesis are recent; epidemiological studies (13,14) in which a hyperdynamic circulation was predictive for the development of NIDDM (13). Also, in essential hypertension, an established state of insulin resistance and concomitant hyperinsulinemia (1), it is presumed that the initial hyperdy namic (hyperkinetic) circulation (15,41)) evolves into estab lished hypertension with increased peripheral resistance (50), With the use of the [:lIi)NE kinetic tracer technique, tin increased sympathetic* activation in response to insulin in hypertensive compared with normal subjects has been re ported (51), which may indicate that this group is at least not resistant to the sympathooxcitatory effect; of insulin. However, we are not able to actually show this postulated increased sympathetic activity in our patients; nor can it be proved that hypertension eventually will develop. The alter native interpretation could be that insulin-stimulated sympa thetic neural activity is not involved in the pathogenesis of hypertension in NIDDM.
In conclusion, we report, that nonobese patients in the early phase of NIDDM, who are hyperinsuiiuemie and resis tant to the metabolic oiled, of insulin, are normally respon sive to the effects of insulin on vascular tone and sympathetic activity. Furthermore, the sympathetic nervous system is normally responsive to stimuli. This means that during daily life an excessive sympathetic neural outflow could exist. This fact could be an explanation for the increased incidence of hypertension and/or cardiovascular disease in this group and contribute to a hyperdynamic circulation» probably inducing secondary changes in time, Hyperinsulinemia did not change the absolute responses to sympathetic4 stimulation. The cardiovascular effects of insu lin warrant further investigation, samples. We especially thank the patients and healthy vol unteers who participated in this study.
